National Vision (NASDAQ:EYE) PT Raised to $37.00 at Jefferies Financial Group

National Vision (NASDAQ:EYE) had its price target upped by analysts at Jefferies Financial Group from $35.00 to $37.00 in a research report issued to clients and investors on Thursday, AnalystRatings.com reports. The firm presently has a “buy” rating on the stock. Jefferies Financial Group’s target price points to a potential upside of 15.66% from the stock’s current price.

Several other equities analysts have also recently weighed in on the company. BidaskClub raised National Vision from a “sell” rating to a “hold” rating in a research report on Thursday, April 9th. ValuEngine cut National Vision from a “buy” rating to a “hold” rating in a report on Tuesday, April 14th. Citigroup upped their price target on National Vision from $31.00 to $36.00 in a report on Wednesday, June 10th. Berenberg Bank reaffirmed a “buy” rating and issued a $27.00 price target on shares of National Vision in a report on Monday, April 13th. Finally, TheStreet raised National Vision from a “d” rating to a “c-” rating in a report on Tuesday, June 9th. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. National Vision presently has an average rating of “Buy” and a consensus price target of $35.10.

Shares of EYE traded up $0.95 during trading hours on Thursday, hitting $31.99. 710,101 shares of the company were exchanged, compared to its average volume of 550,900. The company has a market cap of $2.49 billion, a PE ratio of 43.11 and a beta of 2.02. The firm’s 50 day moving average is $30.02 and its 200-day moving average is $28.79. National Vision has a 52 week low of $11.70 and a 52 week high of $39.88. The company has a debt-to-equity ratio of 1.33, a quick ratio of 1.08 and a current ratio of 1.53.

National Vision (NASDAQ:EYE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.09. National Vision had a return on equity of 7.62% and a net margin of 1.45%. The business had revenue of $469.70 million during the quarter, compared to analysts’ expectations of $434.95 million. During the same quarter in the previous year, the firm earned $0.33 EPS. The firm’s revenue was up 1.8% compared to the same quarter last year. As a group, equities analysts forecast that National Vision will post -0.31 earnings per share for the current fiscal year.

Several institutional investors and hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. grew its position in National Vision by 14.2% during the 1st quarter. JPMorgan Chase & Co. now owns 7,698,550 shares of the company’s stock worth $149,506,000 after acquiring an additional 954,841 shares during the last quarter. William Blair Investment Management LLC bought a new stake in National Vision during the 1st quarter worth approximately $16,935,000. Norges Bank bought a new stake in National Vision during the 4th quarter worth approximately $22,688,000. Emerald Advisers LLC grew its position in National Vision by 314.1% during the 2nd quarter. Emerald Advisers LLC now owns 732,250 shares of the company’s stock worth $22,348,000 after acquiring an additional 555,410 shares during the last quarter. Finally, Emerald Mutual Fund Advisers Trust grew its position in National Vision by 300.8% during the 2nd quarter. Emerald Mutual Fund Advisers Trust now owns 664,558 shares of the company’s stock worth $20,282,000 after acquiring an additional 498,768 shares during the last quarter.

National Vision Company Profile

National Vision Holdings, Inc, through its subsidiaries, operates as an optical retailer primarily in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products, as well as eye exams through its America's Best, Eyeglass World, Vista Optical, and Vista Optical Military, as well as Vision Center brand stores; and provides health maintenance organization, vision care benefit plan, and optometric services.

See Also: Differences Between Momentum Investing and Long Term Investing

Analyst Recommendations for National Vision (NASDAQ:EYE)

Receive News & Ratings for National Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Vision and related companies with MarketBeat.com's FREE daily email newsletter.